Skip to content

Clinical trials

Adenocarcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Taiwan Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20071
20082
20092
20102
20142
20151
20166
20174
20183
20192
20202
20213
20222
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting7
Recruiting5
Terminated5
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.3
AstraZeneca3
Novartis Pharmaceuticals3
Australasian Gastro-Intestinal Trials Group2
Blueprint Medicines Corporation2
Eli Lilly and Company2
Maia Biotechnology2
National Taiwan University Hospital2
Sumitomo Pharma America, Inc.2
AbGenomics B.V Taiwan Branch1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma41
Neoplasms18
Carcinoma, Non-Small-Cell Lung15
Stomach Neoplasms12
Carcinoma11
Neoplasms by Site9
Digestive System Neoplasms8
Lung Neoplasms8
Neoplasms by Histologic Type7
Digestive System Diseases6

Trials

Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.